Collaborators

Researchers, clinicians, and professionals across industry and academia. See below for a list of active collaborators.

 
Jonathan Schooler

Jonathan Schooler, PhD

Cognitive Psychologist; Distinguished Professor of Psychological & Brain Sciences

Dr. Jonathan W. Schooler is a Cognitive Psychologist, Research Scientist, and Distinguished Professor of Psychological and Brain Sciences at the University of California, Santa Barbra, with over 350 peer-reviewed, scientific articles. His research centers on mind wandering, mindfulness, meta-awareness, creativity, and (most recently) psychedelics. Dr. Schooler’s work is often featured in major media outlets, such as The New York Times, The New Yorker, and Nature Magazine.


University of California, Santa Barbara

UCSB | META Lab | LinkedIn | Google Scholar


Lynnette Averill

Lynnette Averill, PhD

Clinical Psychologist; Associate Professor of Psychiatry & Behavioral Sciences

Dr. Lynnette A. Averill is a Clinical Research Psychologist, Associate Professor of Psychiatry and Behavioral Sciences at Baylor College of Medicine, and an Assistant Professor Adjunct of Psychiatry at Yale School of Medicine, with nearly 100 peer-reviewed, scientific articles. Her work focuses on pharmacoimaging trials of serotonergic psychedelics (e.g., MDMA and psilocybin) on improving trauma, suicidal ideation, and cognitive function; and the neural underpinnings of these behavioral changes.


Baylor College / Yale School of Medicine

Baylor | Yale | LinkedIn | Google Scholar


Reid Robison

Reid Robison, MD, MBA

Psychiatrist; Chief Clinical Officer; Co-Founder & Medical Director

Dr. Reid Robison is a Psychiatrist, Chief Clinical Officer of Numinus Wellness, Co-Founder of Cedar Psychiatry, Medical Director of the Center for Change, and former MAPS Investigator. He has led over 200 clinical trials and published numerous peer-reviewed, scientific articles. Dr. Robison’s research centers on eating disorders, psychedelics, and mind-body interventions; and is often featured in major media outlets, such as Forbes, The Psychiatric Times, and The Pharmacy Times.


Numinus Wellness | Cedar Psychiatry

Numinus | Personal | LinkedIn | Google Scholar


Daniel Smilek

Daniel Smilek, PhD

Cognitive Psychologist; Consulting Neuroscientist; Professor of Psychology

Dr. Daniel Smilek is a Cognitive Neuroscientist and Professor of Psychology at the University of Waterloo in Canada, with over 250 peer-reviewed, scientific articles. His work has appeared in top scientific journals, such as Nature, Psychological Science, and Trends in Cognitive Sciences, and has been featured in popular media outlets, like The Economist. Dr. Smilek’s research examines factors that impact attention during everyday activities, such as mind wandering and media multitasking.


The University of Waterloo

Waterloo | Attention Lab | Google Scholar


Michael Gaffrey

Michael Gaffrey, PhD

Clinical Psychologist; Craig Yabuki Research Chair for Mental & Behavioral Health

Dr. Michael S. Gaffrey is a Clinical Research Psychologist, Associate Professor of Pediatric Psychology and Developmental Medicine, and Craig Yabuki Research Chair for Mental and Behavioral Health at the Medical College of Wisconsin, with numerous peer-reviewed, scientific articles. His work focuses on early detection and interventions for autism and other developmental disorders, plus early childhood depression. Dr. Gaffrey also has a peak interest in psychedelic therapy.


Medical College of Wisconsin

Madison | Duke | LinkedIn | Google Scholar


Liliana Galindo, MD, PhD

Psychiatrist; Medical Leader of Psychosis; Assistant Professor of Psychiatry

Dr. Liliana Galindo is a Psychiatrist at the CPFT NHS Trust, and a Medical Leader of Psychosis and Assistant Professor of Psychiatry at the University of Cambridge in England, with nearly 100 peer-reviewed, scientific articles. Dr. Galindo also founded the first Psychedelic Research Group at Cambridge, spearheading its first trial on a synthetic variant of MDMA. Her work focuses on resilience and mental illness, specifically psychosis, along with psychoactive substances and harm reduction.


University of Cambridge | CPFT NHS Trust

Cambridge | LinkedIn | Google Scholar


Nathaniel Barr, PhD

Cognitive Psychologist; Professor of Creativity & Creative Thinking

Dr. Nathaniel Barr is a Cognitive Psychologist, Professor of Creativity and Creative Thinking at Sheridan College in Canada, and Senior Innovation Advisor at BEworks. He has published on creativity, belief and reasoning, thinking and technology, and the future of education and work. Dr. Barr’s academic and industry projects often involve bridging scientific and creative disciplines. His work has been covered in Scientific American, The Washington Post, and The Wall Street Journal.


Sheridan College | BEworks

Sheridan | BEworks | LinkedIn | Google Scholar


Saj Razvi

Saj Razvi, LPC

Psychotherapist; Clinical Investigator; Founder & Director of Education

Mr. Saj Razvi is a Trauma-Informed Therapist and the Founder and Director of Education at the Psychedelic Somatic Institute, where he co-developed ‘psychedelic somatic interactional psychotherapy’ (PSIP), a novel and primary consciousness oriented psychotherapy. Mr. Razvi previously served as a Clinical Investigator for the pivotal Phase 2 trial of MDMA-assisted therapy for PTSD, sponsored by MAPS. His work centers on somatic-based psychedelic medicine.


Psychedelic Somatic Institue

PSI | Trauma Project | Articles | Audible